Welcome Message

We cordially invite all distinguished scientists, young researchers, academics, business delegations, former congress attendees, and students from around the world to participate in 17^th World Congress on Virology, Emerging Diseases & Vaccines which will held on February 23-24, 2022 in Vienna, Austria.

It is an international convention where researchers, techniques, frameworks, advances, standards, and applications related to virology will be presented and discussed.

The congress will undoubtedly benefit scholars and practitioners in this field. The event will feature a variety of famous speakers who will present their most recent research findings that will transform the science field for better future.

About Conference

Virology is the scientific discipline concerned with the study of the biology of viruses and viral diseases, including the distribution, biochemistry, physiology, molecular biology, ecology, evolution and clinical aspects of viruses.

The Conference highlights will include Viral Pathogenesis, Corona virus, Diagnostic Virology, Plant Virology, Marine Virology, Veterinary Virology,Modes of Transmission of Infectious Diseases, Global Trends in Emerging Infectious Diseases, Clinical of Infectious Diseases, Viral Infectious Diseases, bacterial Infectious Diseases, Fungal Infectious Diseases, Parasitic Infectious Diseases, Diagnosis of Infectious Diseases etc.

Target Audience:

• Virology Students, Scientists
• Virology Researchers
• Virology Faculty
• Medical Colleges
• Virology Associations and Societies
• Research Labs
• Manufacturing Medical Devices Companies

Sessions / Tracks

1. General Virology and Basic Science

Viral infections is one of the major cause of human and animal disease. Virus genomes are very small and they are incredibly diverse and subject to rapid genetic change. Viruses have their own ways of transmission. The mobility of animals increases the mechanisms of viral transmittance that have evolved, whereas plants remain immobile and thus viruses must rely on environmental factors to be transmitted between hosts. Transmission of viruses:

• Mouth

• Eyes

• Nose

• Airdroplets

2 .Viral Pathogenesis, Virulence and Latency       

Viral pathogenesis is the investigation of how organic infections cause ailments in their objective hosts, usually carried out at the cellular or molecular level. Vector-borne diseases are contaminations transmitted by the chomp of tainted arthropod species, for example, mosquitoes, ticks, sandflies, blackflies, etc. A blood-borne disease is one that can be spread through sullying by blood and other body liquids. RNA quieting controls quality expression to direct improvement, genome solidness and uneasiness impelled responses.

• Blood borne disease

• Vector borne disease.

 3: Viruses and Diseases

An alphavirus belongs to the group IV Togaviridae family of viruses according to the grouping of collection considering viral genome association exhibited by David Baltimore. Filoviruses belong to a virus family called Filoviridae and can bring about serious hemorrhagic fever in people and nonhuman primates. Picorna viruses are non-wrapped, positive-stranded RNA infections with an icosahedral capsid. West Nile infection is a mosquito-borne zoonotic arbovirus having a place with the sort Flavivirus in the family Flaviviridae.

Common viral disease are:

• Chickenpox.

• Flu (influenza)

• Herpes.

• Human immunodeficiency virus (HIV/AIDS)

• Human papillomavirus (HPV)

4: Therapeutic Approaches and Targets for Viral Infections

DNA immunization is a novel method used to efficiently fortify humoral and cellular immune responses to protein antigens. Viral vaccines contain either inactivated viruses or constricted viruses .Inactive viral vaccines contain a virus, which have lost their ability to replicate and in order for it to bring about a response it contains more antigen than live immunizations. Allergy immunotherapy is a clinically documented efficacious treatment, which may considerably reduce the patient’s allergic symptoms and the need for traditional, symptom-relieving medication. Antiviral drugs are a class of medication utilized particularly for treating viral contaminations.

Antiviral Drugs :

• oseltamivir phosphate (available as a generic version or under the trade name Tamiflu®),

• zanamivir (trade name Relenza®)

• peramivir (trade name Rapivab®), and.

• baloxavir marboxil (trade name Xofluza®).

 5: Viral Immunology

Cell signaling is part of a complex system of communication that administers basic cellular activities and coordinates cell activities. A Neutralizing antibody is an antibody which safeguards a cell from an antigen or infectious body by inhibiting or neutralizing any effect it has biologically. Cell-mediated immunity is an immune response that does not involve antibodies, but rather involves the activation of phagocytes, antigen-specific cytotoxic T-lymphocytes, and the release of various cytokines in response to an antigen.

• Neutralizing antibody

• Cell mediated immunity

 6.Global Epidemiology of HIV/AIDS, STDs, & STIs

The human immunodeficiency virus is a lentivirus that causes HIV infection and AIDS.HIV diagnosis is done by testing your blood or saliva for antibodies to the virus. HIV/AIDS clinical trials are research studies done to have a better approach, distinguish, or treat HIV/AIDS. Clinical trials are the fastest way to determine if new medical approaches to HIV/AIDS are safe and effective in people.

• NAT

• Antigen/antibody test

• Antibody tests

 7: Current Focus in Virology Research

Stem cell therapy treatment is the usage of stem cells to treat or keep an infection or condition. Bone marrow transplant is the most broadly utilized stem cell treatment, however a few treatments got from umbilical core blood are additionally being used. Clinical or therapeutic virology is a branch of medication which comprises in detaching as well as in describing one or a few viruses in charge of some human pathology by different distinctive prompt or circumlocutory systems.

Topics of research:

• Boosting Imunity to COVID-19 vaccine

• A reconstruction of early cryptic Covid spread

• Clinical aspects of viruses

8: Bacterial Virology

Significant point driving development of vaccine technology market join rising pervasiveness of contaminations, expanding government exercises for developing immunization over the globe, growing association interests in inoculation change, and rising exercises by non-government relationship for immunizations. Clinical trials are research concentrates that examine whether a therapeutic strategy, treatment, or gadget is safe and effective for people.

Most Deadly Bacterial Infections

• Tuberculosis.

• Anthrax.

• Tetanus.

• Leptospirosis.

• Pneumonia.

• Cholera.

• Botulism.

• Pseudomonas Infection.

9: Diagnostic Virology & Molecular Analysis

Diagnostics market is still incipient and is predicted to reach $3.5 billion by 2020 from the radical value of $1.1 billion, growing at a CAGR of about 20% during the predicted period of 2014 to 2020. The Global Diagnostic Market is categorized based on indication, geography and technology.  The crucial drivers for this market are the discovery and increase in utilization and study of biomarkers and co-development of drugs and various therapies corresponding to these diagnostics. Nevertheless, the costs pertinent with drug development could contravene the growth of diagnostic market. Scope for this market prevails in progressing diagnostics for various infectious and hereditary conditions.

Diagnostic virology is now a crux in pathology and in medical practice. Various approaches are being optimized for the laboratory diagnosis of viral infections, antigen and nucleic acid detection, and serology. The technique of viral culturing is dwindling as novel immunological and molecular tests detect and provide accurate and more rapid results. In the last decade, both qualitative and the quantitative nucleic acid detection techniques has had an extensive impact on viral diagnostics.

• Viral Culturing'
• Viral Diagnostic

10. New Innovations in Viral Infections

Viral Outbreaks generally are pandemic, mostly transmitted via tourists, especially air travelers. These outbreaks have a very serious and hard impact on the global economy. These impacts can be of short term and long term. These impacts sometimes are so severe that it causes about 80% financial impact globally; in the recent Ebola outbreak in 2015, the short term impact was an estimated $359 million in Guinea, Sierra Leone and Liberia alone, which were the severe worst it countries, with the long term impact being $809 million.Infectious diseases pose a severe threat to global population health and are majorly devastating for the tropical countries as these infectious agents can easily thrive on those climatic conditions

• New technology enablesdifferentiation of Bacterial and Viral infection

• Innovative appaaroaches to viruses diagnosis and control

11.  Organ specific Cancer and Tumor virology

Viral gastroenteritis is an inflammation of the stomach and intestines created by one of any number of viruses. It is otherwise called as the stomach flu. Hepatocellular carcinoma is the most well-known sort of liver cancer. Most examples of HCC are secondary to either a viral hepatitis contamination or cirrhosis. Simian infection 40, a polyomavirus that is found in both monkeys and humans. It was named for the effect it made on contaminated green monkey cells, which showed a strange number of vacuoles.

• Viral Gastroenteritis

• Hepatocellular carcinomas

• HPV associated cervical cancers

• Human Herpes virus and cancers

• Simian virus 40

• Other cancer associated viral infections

12.  Respiratory and Emerging/Re-emerging Viruses

An alphavirus has a place with the gathering IV Togaviridae group of infections according to the arrangement of grouping considering viral genome association displayed by David Baltimore. Filoviruses fit in with an virus family called Filoviridae and can bring about serious hemorrhagic fever in people and nonhuman primates. Picornaviruses are non-wrapped, positive-stranded RNA infections with an icosahedral capsid. West Nile infection is a mosquito-borne zoonotic arbovirus having a place with the genus Flavivirus in the family Flaviviridae.

• Flavivirus
• Alphavirus

13. Coronaviruses COVID-19

Corona viruses area unit a gaggle of viruses that cause diseases in mammals and birds. In humans, coronaviruses cause tract infections that area unit generally delicate, like the respiratory disease, although rarer forms like respiratory disease, MERS, and COVID-19 are often fatal. Symptoms vary in alternative species: in chickens, they cause AN higher tract illness, whereas in cows and pigs they cause looseness of the bowels. There area unit nevertheless to be vaccines or antiviral medication to stop or treat human coronavirus infections. After-effects of covid-19 on human body:

• Organ damage caused by COVID-19
• Blood clots and blood vessel problems
• Problems with mood and fatigue
• Many long-term COVID-19 effects still unknown

14: Human Vaccines - Infectious & Non Infectious Diseases

A vaccine is an inactivated form of bacteria or virus that is injected into the body to simulate an actual infection. Because the injected microorganisms are 'dead,' they don't cause a person to become sick. Instead, vaccines stimulate an immune response by the body that will fight off that type of illness. It covers infectious disease targets and non-infectious disease targets. To generate vaccine-mediated protection is a complex challenge. Currently available vaccines have largely been developed empirically, with little or no understanding on how they activate the immune system. Their early protective efficacy is primarily conferred by the induction of antigen-specific antibodies. However, there is more to antibody-mediated protection than the peak of vaccine-induced antibody titers.

Live-attenuated vaccines

• Measles, mumps, rubella (MMR combined vaccine)

• Rotavirus.

• Smallpox.

• Chickenpox.

• Yellow fever.

15. Vaccine Research & Development

Vaccine Development is an activity that focuses on a variety of technological initiatives and applied research, which enhance and promote improved systems and practices for vaccine safety. In the past year, the unprecedented Ebola disease outbreak galvanized research and industry response and as we continue to search for solutions, we must review the lessons learned in order to overcome the current challenges. Vaccines development is a long, complex process, often lasting 10-15 years and involving a combination of public and private involvement. The current system for developing, testing, and regulating vaccines developed during the 20th century as the groups involved standardized their procedures and regulations.

The general stages of the development cycle of a vaccine are:

• Exploratory stage

• Pre-clinical stage

• Clinical development

• Regulatory review and approval

• Manufacturing

• Quality control

16: Next-Generation Vaccine Delivery Technologies

Drug delivery systems are engineered technologies for the targeted delivery and/or controlled release of therapeutic agents. Drugs have long been used to improve health and extend lives. The practice of drug delivery has changed dramatically in the last few decades and even greater changes are anticipated in the near future. Biomedical engineers have not only contributed substantially to our understanding of the physiological barriers to efficient drug delivery—such as transport in the circulatory system and drug movement through cells and tissues—they have contributed to the development of a number of new modes of drug delivery that have entered clinical practice.  Role of vaccine delivery technologies includes rational development of vaccines, achieving immunization goals, supporting best clinical practice.

Vaccines continue to revolutionize our ability to prevent disease and improve health. With every technological advance, we are able to extend the benefits of vaccines to more people and provide better protection from life-threatening infectious diseases.

• Recombinant vaccines

• DNA vaccines

• Peptide based vaccines

17. Vaccine Adjuvants          

Vaccine adjuvants – is an ingredient of a vaccine that helps create a stronger immune response in the patient’s body.  In other words, adjuvants help vaccines work better. Some vaccines made from weakened or dead germs contain naturally occurring adjuvants and help the body produce a strong protective immune response. However, most vaccines developed today include just small components of germs, such as their proteins, rather than the entire virus or bacteria. These vaccines often must be made with adjuvants to ensure the body produces an immune response strong enough to protect the patient from the germ he or she is being vaccinated against.

18. Human Preventive & Therapeutic Vaccines

A preventative vaccine is administered to a person who is free of the targeted infection. By introducing a part of the virus or an inactive virus (which acts like a decoy) into the body, the immune system reacts by producing antibodies. Preventive vaccines are widely used to prevent diseases like polio, chicken pox, measles, mumps, rubella, influenza (flu), and hepatitis A and B.In addition to preventive vaccines, there are also “therapeutic vaccines”. Therapeutic vaccines are currently developed for chronic viral infections:

• human papillomavirus (HPV)

• human immunodeficiency virus (HIV)

• hepatitis B (HBV)

• HCV) virus infections

19. Vaccines Safety & Efficancy

Vaccines are the best defense we have against serious, preventable, and sometimes deadly contagious diseases. Vaccines are some of the safest medical products available, but like any other medical product, there may be health risk. Accurate information about the value of vaccines as well as their possible side-effects helps people to make informed decisions about vaccination. The safety of vaccines is carefully monitored, starting early in the product development and continuing for as long as the vaccine is being used.

Cultural Perspectives on Vaccination:

• Individual versus Public Health Stances

• Religious Perspectives and Vaccine Objections

• Suspicion and Mistrust of Vaccines

20. Vaccines Business Development

Collaboration plays a major part in the success of Vaccines Business. This is exemplified in the relationships built, products launched and lives improved.

Vaccines Business development: comprise a number of tasks and processes generally aiming at developing and implementing growth opportunities within and between organizations. It is a subset of the fields of business, commerce and organizational theory. Vaccine development programs face several challenges that set them apart from other types of healthcare product development programs.

Market Analysis

New York, United States : The Report on Companion Animal Diagnostics Market by Decisive Markets Insights was released in the middle of Covid -19 after a thorough analysis of the top players and primary interviews with key industry figures. A market study from Companion Animal Diagnostics Market examines the market size, segmentation, future trends, growth rate, drivers and challenges, as well as the sales channels and distributors. As part of preparing this market research report, the market SWOT analysis is carried out as well as many other standard steps of research, analysing and collecting data. A devoted focus on customer needs, it’s an in-depth analysis of multiple factors influencing the market. The best-practice models and research methodologies are used to achieve a comprehensive market analysis for the purpose of providing clients with market segmentation and insights that are accurate and relevant for their business initiatives.

The global vaccines market is projected to reach USD 58.4 billion by 2024 from USD 41.7 billion in 2019, at a CAGR of 7.0% during the forecast period. The growth of this market is majorly attributed to the high prevalence of infectious diseases, increasing company initiatives to enhance vaccine R&D, growing government support for vaccine development, and the rising focus on immunization. However, the huge capital investments required for developing vaccines may restrain market growth.

Major Socities & Companies

Related associations and Companies:

·American Society for Virology

·Australasian Virology Society

·Brazilian Society for Virology

·Canadian Society for Virology

·German Society for Virology

·Italian Society for Virology

·Spanish Society for Virology

·Swedish Society for Virology

·Viruses: National Multiple Sclerosis Society

·Infectious Diseases Society of America

Companies:

·SRI International

·NCBiotech Company

·Scientific Companies

·PhRMA

·Hepatitis B Foundation

·Pfizer

·Gilead Sciences

·MERCK

·CMC biologics

Past Conference Report

Conference Series LLC Ltd  hosted the “Euro Virology 2020” Webinar, during June 24-25, 2020 with the theme, “An outbreak of 2019 Novel Coronavirus Diseases (COVID-19) in Worldwide in the aspect of Virology”, which was a great success. Eminent keynote speakers from various reputed institutions and organizations addressed the gathering with their resplendent presence.

We extend our grateful thanks to all the momentous speakers, conference participants who contributed towards the successful run of the Webinar.

Euro Virology 2020 Webinar witnessed an amalgamation of peerless speakers who enlightened the crowd with their knowledge and confabulated on various latest and exciting innovations in all areas of Virology Research.

Euro Virology Organizing Committee extends its gratitude and congratulates the Honorable Moderators of the conference.

Conference Series LLC Ltd extends its warm gratitude to all the Honorable Guests and Keynote Speakers of “Euro Virology 2020”.

• Vsevolod A Zinserling, Saint-Petersburg University, Russia

• Alfredo Berzal-Herranz, Instituto de Parasitología y Biomedicina “López-Neyra” (IPBLNCSIC), Spain

Conference Series LLC Ltd is privileged to felicitate Euro Virology 2020 Webinar Organizing

Committee, Keynote Speakers, Chairs & Co-Chairs and also the Moderators of the conference whose support and efforts made the webinar to move on the path of success. Conference Series LLC LTD thanks every individual participant for the enormous exquisite response. This inspires us to continue organizing events and conferences for further research in the field of Virology.

Conference Series LLC Ltd is glad to announce its “17^th World Congress on Virology, Emerging Diseases & Vaccines, which will be held during Feb 23-24, 2022 at Vienna, Austria. We cordially welcome all the eminent researchers, Virologists, Microbiologists, Experts in vaccine development and other specialists to discuss the challenges of the virus research, Virology Faculty, Vaccine developing companies, Young researchers, students and delegates to take part in this upcoming conference to witness invaluable scientific discussions and contribute to the future innovations in the field of Virology with 20% abatement on the Early Bird Prices.

Bookmark your dates for “Virology 2022, Vienna, Austria” as the Nominations for Best Poster Awards and Young Researcher Awards are open across the world.